18099-59-7

Basic information

• Product Name: 4'-DECYLOXYACETOPHENONE
• Synonyms: 4'-DECYLOXYACETOPHENONE;4''-DECYLOXYACETOPHENONE 99%;4'-Decyloxyacetophenone,99%
• CAS NO: 18099-59-7
• Molecular Formula: C₁₈H₂₈O₂
• Molecular Weight: 276.41
• Mol File: 18099-59-7.mol
• Article Data: 16

Chemical Properties

• Melting Point: 35-37 °C
• Boiling Point: 379.32°C (rough estimate)
• Flash Point: 154.3 °C
• Appearance: white flakes
• Density: 0.9804 (rough estimate)
• Refractive Index: 1.5510 (estimate)
• CAS DataBase Reference: 4'-DECYLOXYACETOPHENONE(CAS DataBase Reference)
• NIST Chemistry Reference: 4'-DECYLOXYACETOPHENONE(18099-59-7)
• EPA Substance Registry System: 4'-DECYLOXYACETOPHENONE(18099-59-7)

Safety Data

• Safety Statements: 24/25
• Hazardous Substances Data: 18099-59-7(Hazardous Substances Data)

Usage

Chemical Properties

White flakes

Upstream product

• 112-29-8 1-bromo dodecane 
• 99-93-4 4-Hydroxyacetophenone 
• 1310-73-2 sodium hydroxide 

Downstream Products

• 82935-11-3 1-(4-decyloxy-phenyl)-3-piperidino-propan-1-one 
• 385433-41-0 3-[4-decyloxyphenyl]-1H-pyrazole 
• 877611-05-7 2-(4-decyloxybenzoyl)allyldimethylamine 
• 69374-89-6 1,4-Bis<4-(decyloxy)phenyl>-1,3-butadiyne 
• 115573-46-1 4-n-decyloxyphenylacetylene 
• 1198620-25-5 1-(4-decyloxyphenyl)-3-hydroxy-2-propen-1-one 
• 1240347-24-3 C₂₅H₃₁Cl₅N₃O₃P₃ 
• 1220515-52-5 (E)-1-[4-(decyloxy)phenyl]-3-[4-hydroxyphenyl]prop-2-en-1-one 
• 1385138-19-1 1,4-bis(5-(4-(decyloxy)phenyl)-1H-pyrazol-3-yl)benzene 
• 1385138-14-6 1,3-bis(5-(4-(decyloxy)phenyl)-1H-pyrazol-3-yl)benzene 

Relevant articles and documents

Liquid crystal behavior, photoluminescence and gas sensing: A new series of ionic liquid crystal imidazole and benzoimidazole bearing chalcone groups, synthesis and characterization

Four new series of chalcones containing imidazole bromonium and benzimidazole bromonium salts with spacer alkyl chains (Cn, n = 2 and 4) were synthesized and the chemical structure, thermal behavior, photoluminescence and gas sensing were characterized by

Design, synthesis, and discovery of 5-((1,3-diphenyl-1H-pyrazol-4-yl)methylene)pyrimidine-2,4,6(1H,3H,5H)-triones and related derivatives as novel inhibitors of mPGES-1

Human mPGES-1 has emerged as a promising target in exploring a next generation of anti-inflammatory drugs, as selective mPGES-1 inhibitors are expected to discriminatively suppress the production of induced PGE2 without blocking the normal biosynthesis of other prostanoids including homeostatic PGE2. Therefore, this therapeutic approach is believed to reduce the adverse effects associated with the application of traditional non-steroidal anti-inflammatory drugs (tNSAIDs) and selective COX-2 inhibitors (coxibs). Identified from structure-based virtue screening, the compound with (Z)-5-benzylidene-2-iminothiazolidin-4-one scaffold was used as lead in rational design of novel inhibitors. Besides, we further designed, synthesized, and evaluated 5-((1,3-diphenyl-1H-pyrazol-4-yl)methylene)pyrimidine-2,4,6(1H,3H,5H)-triones and structurally related derivatives for their in vitro inhibitory activities. According to in vitro activity assays, a number of these compounds were capable of inhibiting human mPGES-1, with the desirable selectivity for mPGES-1 over COX isozymes.

Fluorescent columnar bis(boron difluoride) complexes derived from tetraketonates

Three new series of bis-(boron difluoride) complexes 1a-c derived from substituted tetraketonates 2a-c are reported, and their mesomorphic and optical properties have been investigated. Two single crystals of mesogenic ligand 2a (n = 6) and nonmesogenic d